Table 1.

The association between MS type and the participants’ answers to each question

Question		Multiple Sclerosis (MS) Types				P*
		No. (%)
		RRMS	PPMS	SPMS	CIS
The most concerns of the patients with Multiple Sclerosis (MS) about coronavirus	The high prevalence of coronavirus	40 (42.1)	4 (22.2)	3 (27.3)	2 (100)	0.05
	More complication of coronavirus in patients with MS	16 (16.8)	3 (16.7)	3 (27.3)	0 (0)
	Quarantine during coronavirus outbreak	11 (11.6)	1 (5.6%)	1 (9.1)	0 (0)
	Death because of coronavirus infection	17 (17.9)	1 (5.6)	1 (9.1)	0 (0)
	MS worsening by catching coronavirus	11 (11.6)	9 (50.0)	3 (27.3%)	0 (0)
	I will be cured and my disease process will be similar to the others.	16 (16.3)	10 (55.6)	3 (27.3)	2 (100)
What will be the results if you catch new coronavirus?	I will be cured, but the treatment will take more time for me.	33 (33.7)	6 (33.3)	7 (63.6)	0 (0)	0.001
	I will be cured, but the complications of COVID-19 infection will affect me.	17 (17.3)
	Catching COVID-19 will result in my death.	32 (32.7)	3 (11.1)	1 (9.1)	0 (0)
The effect of coronavirus on MS	COVID-19 infection does not affect MS symptoms.	38 (39.2)	3 (23.1)	4 (40.0)	1 (50.0)	0.84
	COVID-19 may cause relapse.	30 (30.9)	5 (38.5)	4 (40.0)	1 (50.0)
	COVID-19 infection may cause MS symptoms worsening.	29 (29.9)	5 (38.5)	2 (20.0)	0 (0)

MS: Multiple Sclerosis; RRMS: Relapsing-Remitting MS; PPMS: Primary Progressive MS; SPMS: Secondary Progressive MS; CIS: Clinically Isolated Syndrome

^*The Chi-squared test